Brief: Medicinova Announces Mn-001 Abstract Regarding Lipid Metabolism In Nash/Nafld Accepted For Presentation At The Liver Meeting 2021
01/09/2021 12:35
Sept 1 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA ANNOUNCES MN-001 ABSTRACT REGARDING LIPID
METABOLISM
IN NASH/NAFLD ACCEPTED FOR PRESENTATION AT THE LIVER MEETING
2021
Source text for Eikon: ID:nGNX19DwbM
Further company coverage: MNOV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake